Your browser doesn't support javascript.
loading
Addition of anti-neu antibody to local irradiation can improve tumor-bearing BALB/c mouse survival through immune-mediated mechanisms.
Ma, Sun Young; Song, Hyunkeun; Park, Jin-Hee; Choi, Jae-Hyeog; Kim, Jin-Ho; Kim, Ki Hyang; Park, SungJae; Park, Dong Hyen; Kang, Mi Seon; Kwak, Minjung; Fu, Yang-Xin; Choi, Inhak; Cho, Heunglae; Park, SaeGwang.
Afiliação
  • Ma SY; a Department of Radiation Oncology, Kosin University College of Medicine, Busan, 602-702, Republic of Korea.
Radiat Res ; 183(3): 271-8, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25706775
This study investigated the therapeutic effects of combined local irradiation and anti-HER2/neu antibody in a mixed tumor mouse model comprised of a nonmetastatic neu-positive tumor and a metastatic neu-negative tumor. While local irradiation alone could control the primary tumor in a dose-dependent manner, it did not improve mouse survival. Combined treatment comprised of local irradiation and anti-neu antibody of tumor-bearing BALB/c mice significantly improved mouse survival (P < 0.5), even though the tumor growth was similar to that of the irradiated-alone group. The combined treatment significantly reduced metastatic tumor masses in the lung and increased immune cell infiltration in primary tumor tissues. However, immune deficient nude mice with tumors did not exhibit prolonged survival in response to the combined treatment. Collectively, these results show that combined local irradiation and anti-neu antibody can elicit an immune-mediated abscopal effect to extend survival. Although the mechanism for abscopal effects induced by the combined treatment of radiation and anti-HER2/neu antibody was not elucidated, to our knowledge this is the first published study to describe the abscopal effect induced by the combination of local irradiation and the anti-HER2/neu antibody.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anticorpos Anti-Idiotípicos / Receptor ErbB-2 / Imunoterapia Limite: Animals / Female / Humans Idioma: En Revista: Radiat Res Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anticorpos Anti-Idiotípicos / Receptor ErbB-2 / Imunoterapia Limite: Animals / Female / Humans Idioma: En Revista: Radiat Res Ano de publicação: 2015 Tipo de documento: Article